Applications Engineer - Biopharmaceutical Solutions

ABEC opens new manufacturing facility in Wilson, North Carolina. Grand Opening Ceremony Scheduled for September 24, 2026 BETHLEHEM, Pa., Sept. 10, 2026 /PRNewswire/ - ABEC, a global leader in customized solutions and services for biopharmaceutical manufacturing, today announced the grand opening of its newest manufacturing facility in Wilson, North Carolina. The official ribbon-cutting ceremony and facility opening celebration will take place on September 24, 2026, at 9:00am, bringing together company leadership, employees, partners, and community leaders to mark this significant milestone in ABEC's continued growth. The new Wilson facility expands ABEC's global manufacturing network and strengthens the company's ability to support the rapidly growing biopharmaceutical industry with industry-leading equipment, consumables, and integrated process solutions. Strategically located in one of the nation's fastest-growing life sciences regions, the facility enhances ABEC's manufacturing capacity while creating new high-quality manufacturing and technical employment opportunities in eastern North Carolina. "Opening our Wilson facility represents another important milestone in ABEC's commitment to supporting the global biopharmaceutical industry," said Scott Pickering, Chief Executive Officer of ABEC. "This investment expands our manufacturing capabilities, brings us closer to customers in the southeastern United States, and reinforces our ability to deliver the industry's most comprehensive portfolio of bioprocess equipment, consumables, and engineering solutions. We are proud to become part of the Wilson community and look forward to building long-term partnerships throughout the region." The Wilson facility will manufacture bioprocess equipment and consumable products used in the development and production of life-saving biologics, vaccines, and other advanced medicines. The site complements ABEC's existing manufacturing operations in Bethlehem, Pennsylvania; Springfield, Missouri; Fermoy, Ireland; and Kells, Ireland, further strengthening the company's position as the biopharmaceutical industry's largest dedicated manufacturing network for process equipment and solutions. The grand opening event will include a ribbon-cutting ceremony, facility tours, and remarks from ABEC leadership and local community representatives. The celebration will recognize the collaborative efforts of employees, contractors, community partners, and local officials whose support helped make the project a reality. About ABEC Since 1974, ABEC has been a global leader in delivering engineered process solutions and services for manufacturing in the biotech industry. The majority of the world's pharmaceutical and biotechnology companies are ABEC customers, with many of today's leading therapies manufactured using ABEC-engineered equipment and processes. ABEC's unique value is built on deep experience, complete in-house capabilities, a flexible approach, and long-term credibility. From process development and facility design to equipment manufacturing, installation, and support services, ABEC helps customers reduce cost and time to market while maximizing productivity. SOURCE ABEC, Inc.

ABEC, a global leader in engineered solutions and services for biotechnology manufacturing, has introduced its Advanced Therapy Bioreactor (ATB(TM), a revolutionary platform focused on transforming cell expansion for Advanced Therapy Medicinal Products (ATMPs).

Eat Just and its cultivated meat subsidiary GOOD Meat have reached an agreement in principle to settle their legal dispute* with bioreactor supplier ABEC, according to court documents, although the matter has not yet reached a final resolution.In a letter to Judge Wendy Beetlestone dated February 6, attorneys for both parties explained that they “have engaged in serious settlement negotiations over the past few months and have reached an agreement in principle regarding the framework for a settlement agreement and the material terms.“However, due to the complex nature of the claims, defenses, and counterclaims,” they added, “the parties require additional time to draft a binding agreement.”In a court order filed on February 7, Judge Beetlestone agreed to their request for the court to appoint a magistrate judge as settlement master to facilitate a final resolution, but rejected their request for a 30-day stay on the litigation and all case deadlines.Neither party has responded to a request for comment from AgFunderNews.What is the case about?The legal dispute began in March 2023 when ABEC filed a lawsuit accusing GOOD Meat of breach of contract by failing to pay its bills on time.According to ABEC, GOOD Meat owed $62,649,231.79 for work ABEC had already completed. Eat Just, in turn, claimed that ABEC had breached the terms of their contract.ABEC, which had been working with GOOD Meat on pilot cultivated chicken facilities in California and Singapore, signed an agreement with the startup in August 2021. Under the seven-year deal, ABEC would design, manufacture, install and commission multiple 250,000-liter vessels— “the largest known bioreactors for avian and mammalian cell culture”—for a large-scale facility in the US.Given “financing hurdles,” by November 2022, Eat Just/GOOD Meat “recommended the evaluation of a phased approach, creating five 125,000-L bioreactors instead of four 250,000-L bioreactors,” and the two started corresponding over amendments to their agreement.By March 2023, ABEC said it had had no choice but to take legal action over unpaid bills. Eat Just/GOOD Meat responded by filing a series of counterclaims, arguing that the parties never formally ratified amendments to their original agreement, and that ABEC had simply proceeded as if they had.Speaking to AgFunderNews last year, Eat Just founder and CEO Josh Tetrick said he was “not attempting to raise money for a large-scale cultivated meat facility right now” and was instead focusing on process development at the firm’s plant in Alameda, California, and working on new cell lines he claimed would enable more efficient large-scale production.*The case is ABEC, Inc. v. Eat Just, Inc